$25.23
0.060.25%
At close: -
$24.99
-0.24-0.93%
After Hours: Dec 26, 9:19 AM EDT
Tema Oncology ETF (NASDAQ: CANC)
Ticker | Name | Share % | |
---|---|---|---|
REGN | Regeneron Pharmaceuticals, Inc. | 5.87% | |
LN | Astrazeneca Plc | 5.52% | |
MRK | Merck & Co Inc - Common | 4.77% | |
JP | Daiichi Sankyo Co Ltd | 3.94% | |
AS | Argenx Se Spon Adr Each Rep 1 Ord Shs | 3.64% | |
AMGN | Amgen Inc. | 3.39% | |
BPMC | Blueprint Medicines Corp | 3.38% | |
NTLA | Intellia Therapeutics Inc | 3.16% | |
EXEL | Exelixis Inc | 3.16% | |
INCY | Incyte Corp. | 3.03% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
CANC follows a Large Cap Blend investment style.
The top holdings of CANC include: REGN (5.87%), LN (5.52%), MRK (4.77%), JP (3.94%), AS (3.64%). These represent the largest positions in the ETF's portfolio.
The average daily trading volume for CANC is 7.56K shares.